OssDsign AB is a holding company, which engages in the development and sales of medical technology products. Its products are titanium-reinforced calcium phosphate implants, including OssDsign Cranial and OssDsign Catalyst. The company was founded by Håkan Gunnar Engqvist, Carl Thomas Engstrand, Bo Erik Qwarnstrom, and Jonas Åberg on February 4, 2011 and is headquartered in Uppsala, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company